PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
02-Dec-2020 GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States Global Blood Therapeutics, Inc.
02-Dec-2020 UK’s largest ever NHS rare disease diagnosis programme launched by Mendelian and Modality NHS Partnership Mendelian
02-Dec-2020 Nanoform makes US TV debut in Advancements with Ted Danson (CNBC) Nanoform Finland Plc
02-Dec-2020 Coulter Partners secures Chief Executive Officer for ObsEva Coulter Partners
02-Dec-2020 BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years BD (Becton, Dickinson and Company)
02-Dec-2020 RoosterBio Collaborates with Sartorius to Expand Cell and Gene Therapy Manufacturing Platform Technology into South Korea RoosterBio
02-Dec-2020 BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals BioSpecifics Technologies Corp.
02-Dec-2020 WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research Frost & Sullivan
02-Dec-2020 WorldQuant Predictive Joins The Pistoia Alliance WorldQuant Predictive
02-Dec-2020 Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Seelos Therapeutics, Inc.
02-Dec-2020 Qualigen Therapeutics Completes Recertification of Existing AS1411 Drug Supply for Use in Upcoming Clinical Trials Qualigen, Inc.
02-Dec-2020 WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research Frost & Sullivan
02-Dec-2020 Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals Neurotrope, Inc.
02-Dec-2020 BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years BD
02-Dec-2020 Provepharm Life Solutions acquires Apollo Pharmaceuticals USA to continue growth in the United States Andrew Lloyd Associates
02-Dec-2020 Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials Andrew Lloyd Associates
02-Dec-2020 BioInnovation Institute takes in new cohort of promising early-stage innovations BII
02-Dec-2020 Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia Ascentage Pharma
01-Dec-2020 FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer U.S. Food and Drug Administration
01-Dec-2020 Portal Innovations Launching Lab Space at the Fulton Labs Campus One Year Ahead of Schedule Portal Innovations